In conclusion, our results unveil serum MFAP5 as a potential diagnostic, prognostic and therapeutic tool for ICC, providing a novel approach for use in noninvasive screening of ICC. The gene discussed is MFAP5; the disease is intrahepatic cholangiocarcinoma.